StoneCo Ltd (STNE) concluded trading on Wednesday at a closing price of $14.35, with 5.17 million shares of worth about $74.26 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 56.66% during that period and on June 11, 2025 the price saw a gain of about 3.46%. Currently the company’s common shares owned by public are about 254.62M shares, out of which, 248.88M shares are available for trading.
Stock saw a price change of 3.76% in past 5 days and over the past one month there was a price change of 6.93%. Year-to-date (YTD), STNE shares are showing a performance of 80.05% which increased to 8.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $7.72 but also hit the highest price of $15.08 during that period. The average intraday trading volume for StoneCo Ltd shares is 6.41 million. The stock is currently trading 5.55% above its 20-day simple moving average (SMA20), while that difference is up 10.78% for SMA50 and it goes to 31.81% higher than SMA200.
StoneCo Ltd (NASDAQ: STNE) currently have 254.62M outstanding shares and institutions hold larger chunk of about 75.31% of that.
The stock has a current market capitalization of $3.90B and its 3Y-monthly beta is at 1.92. It has posted earnings per share of -$0.78 in the same period. It has Quick Ratio of 1.39 while making debt-to-equity ratio of 1.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for STNE, volatility over the week remained 3.55% while standing at 2.61% over the month.
Stock’s fiscal year EPS is expected to rise by 12.12% while it is estimated to increase by 18.17% in next year.
Coverage by Morgan Stanley stated StoneCo Ltd (STNE) stock as an Underweight in their note to investors on September 05, 2024, suggesting a price target of $7 for the stock. On July 08, 2024, UBS Upgrade their recommendations, while on June 06, 2024, JP Morgan Upgrade their ratings for the stock with a price target of $20. Stock get a Neutral rating from UBS on February 01, 2024.
